Julien's Primer of Drug Action

The fourteenth edition includes new research on and coverage of: the scope of the opioid epidemic in the United States and new drugs used to treat opioid dependence and opioid overdose; therapeutic uses of drugs commonly characterized as recreational including marijuana to treat Alzheimers PTSD and epilepsy; hallucinogenics for the treatment of multiple psychiatric disorders; and ketamine for the treatment of depression; Cannabidiol (CBD) and its therapeutic uses; synthetic drugs including synthetic cannabinoids (Spice and K2) fentanyl derivatives and bath salts; smoking and mental health; the use of genetic testing to predict the efficacy of antidepressants; the effects of e-cigarettes their use in smoking cessation and among young people; the effects of persistent marijuana alcohol and stimulant use in adolescence; the efficacy of antipsychotics to treat dementia Parkinsons bipolar OCD and PTSD.--